Pappalardo Federico, Pieri Marina, Arnaez Corada Blanca, Ajello Silvia, Melisurgo Giulio, De Bonis Michele, Zangrillo Alberto
Department of Anesthesia and Intensive Care.
Department of Anesthesia and Intensive Care.
J Cardiothorac Vasc Anesth. 2015 Aug;29(4):906-11. doi: 10.1053/j.jvca.2014.12.011. Epub 2014 Dec 12.
Weaning from venoarterial extracorporeal membrane oxygenation (VA ECMO) usually is performed without clear guidelines; yet, patients still die after removal of extracorporeal circulation because of inadequate heart or end-organ recovery. The aim of the study was to address the weaning procedure, analyzing the hemodynamic and echocardiographic picture of patients weaned and to identify predictors of poor outcome among this population.
Observational study.
University hospital.
One hundred twenty-nine VA ECMO cases.
None.
Forty-nine patients (38%) were weaned, 7 (5.4%) were bridged to a ventricular assist device, and 6 (5.2%) were listed for heart transplantation. Weaned patients showed a significant increase of pulse pressure (35 [0-50] mmHg before ECMO, 59 [53-67] mmHg at weaning, 61 [51-76] mmHg after ECMO (p<0.001]) and reduction of dose of inotropes (inotropic score [as defined in the text] 20 [14-40] before ECMO, 10 [3-15] at weaning, and 10 [5-15] after ECMO, p<0.001). Left ventricular ejection fraction (LVEF) increased from 19 (0-22.5)% before ECMO to 35 (22-55)% after ECMO (p<0.001). A significant improvement of right ventricular (RV) function was observed in weaned patients (RV dysfunction from 52% to 21%, p<0.001). Among weaned patients, 15 (31%) died. Patients who died after weaning had longer ECMO duration compared to discharged patients (8 [5-11] v 4 [2-6] days, p = 0.01) and more transfusions (22 [10-37] v 7 [0.5-15] units, p = 0.02); survival was lower in patients with central ECMO (postcardiotomy) compared to peripheral ECMO (p = 0.045). Mortality was higher in those with persistence of RV failure, continuous venovenous hemofiltration, higher inotropic score, lower systolic pressure, or higher leucocyte count at weaning.
Successful weaning from ECMO is a multifaceted process, which encompasses consistent recovery of myocardial and end-organ function; LVEF, though improved, is still low at weaning. Hospital survival is correlated significantly to the duration of ECMO support and to bleeding complications.
静脉 - 动脉体外膜肺氧合(VA ECMO)撤机通常在没有明确指南的情况下进行;然而,由于心脏或终末器官恢复不充分,患者在体外循环撤除后仍会死亡。本研究的目的是探讨撤机过程,分析撤机患者的血流动力学和超声心动图表现,并确定该人群中预后不良的预测因素。
观察性研究。
大学医院。
129例VA ECMO病例。
无。
49例患者(38%)成功撤机,7例(5.4%)过渡到心室辅助装置,6例(5.2%)被列入心脏移植名单。撤机患者的脉压显著增加(ECMO前为35[0 - 50]mmHg,撤机时为59[53 - 67]mmHg,ECMO后为61[51 - 76]mmHg,p<0.001),且血管活性药物剂量减少(血管活性评分[如文中所定义]在ECMO前为20[14 - 40],撤机时为10[3 - 15],ECMO后为10[5 - 15],p<0.001)。左心室射血分数(LVEF)从ECMO前的19(0 - 22.5)%增加到ECMO后的35(22 - 55)%(p<0.001)。撤机患者右心室(RV)功能有显著改善(RV功能障碍从52%降至21%,p<0.001)。在撤机患者中,15例(31%)死亡。撤机后死亡的患者与出院患者相比,ECMO持续时间更长(8[5 - 11]天对4[2 - 6]天,p = 0.01),输血次数更多(22[10 - 37]单位对7[0.5 - 15]单位,p = 0.02);与外周ECMO相比,中心ECMO(心脏术后)患者的生存率更低(p = 0.045)。撤机时存在RV衰竭、持续静脉 - 静脉血液滤过、血管活性评分较高、收缩压较低或白细胞计数较高的患者死亡率更高。
成功从ECMO撤机是一个多方面的过程,包括心肌和终末器官功能的持续恢复;LVEF虽有所改善,但撤机时仍较低。医院生存率与ECMO支持时间和出血并发症显著相关。